JP2006273730A - Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method - Google Patents

Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method Download PDF

Info

Publication number
JP2006273730A
JP2006273730A JP2005092553A JP2005092553A JP2006273730A JP 2006273730 A JP2006273730 A JP 2006273730A JP 2005092553 A JP2005092553 A JP 2005092553A JP 2005092553 A JP2005092553 A JP 2005092553A JP 2006273730 A JP2006273730 A JP 2006273730A
Authority
JP
Japan
Prior art keywords
physiological saline
oxygen
infusion
hydrogen
transfusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005092553A
Other languages
Japanese (ja)
Inventor
Wataru Murota
渉 室田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2005092553A priority Critical patent/JP2006273730A/en
Publication of JP2006273730A publication Critical patent/JP2006273730A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a strongly reducing physiological saline and transfusion which contain a large amount of hydrogen and has a low oxidation-reduction potential while containing a large amount of oxygen. <P>SOLUTION: The physiological saline and transfusion having a large amount of hydrogen and a very low oxidation-reduction potential while containing a large amount of oxygen is obtained by dissolving oxygen in a physiological saline and transfusion under a pressure of 1 to 1,000 atm. with the use of a well-known gas-liquid contact device, and thereafter dissolving hydrogen in the oxygen-containing physiological saline and transfusion under a pressure of 1-1,000 atm. The physiological saline and transfusion can be normally used as a reducing physiological saline and transfusion without causing any health problem. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、還元性を持った生理食塩水及び輸液に関するものである。   The present invention relates to a physiological saline solution and an infusion solution having reducibility.

従来からの還元性の生理食塩水及び輸液は水素を加圧して溶解せしめるという一方向からのみの考え方であった。そのため従来からの還元性の生理食塩水及び輸液には身体が必要とする酸素がほとんど含まれていない。ちなみに従来からの水素を加圧下において溶解させた還元性生理食塩水の酸素含有量は０．００ｍｇ／リットル（東亜ＤＫＫ製含有酸素濃度計で計測）であった。つまり酸素が含まれていないということであった。   Conventional reducing saline and infusion solutions were based on only one direction of pressurizing and dissolving hydrogen. For this reason, conventional reducing physiological saline and infusion contain almost no oxygen required by the body. Incidentally, the oxygen content of reductive physiological saline in which conventional hydrogen was dissolved under pressure was 0.00 mg / liter (measured with a contained oxygen concentration meter manufactured by Toa DKK). In other words, oxygen was not included.

そこで、本願の発明者は、身体が必要としている酸素を多く含有しながら、かつ多くの水素を含有し酸化還元性の非常に低い生理食塩水及び輸液を作り出す事を目的とし、種々の検討を重ねこれに成功した。   Therefore, the inventors of the present application have made various studies for the purpose of producing physiological saline and infusion solutions containing a lot of oxygen necessary for the body and containing a lot of hydrogen and having very low redox properties. Repeatedly succeeded.

前記課題を解決するために、本願の請求項１に係る発明は、酸素を０．１ｍｇ／リットル以上含有し、かつ水素濃度が０．１ｐｐｍ以上の生理食塩水又は輸液であることを特徴とする。   In order to solve the above-mentioned problem, the invention according to claim 1 of the present application is a physiological saline solution or an infusion solution containing 0.1 mg / liter or more of oxygen and having a hydrogen concentration of 0.1 ppm or more. .

また、本願の請求項２に係る発明は、ｐＨが３〜１１であり、酸素を０．１ｍｇ／リットル以上含有し、かつ水素濃度が０．１ｐｐｍ以上の生理食塩水又は輸液であることを特徴とする。   The invention according to claim 2 of the present application is a physiological saline or infusion solution having a pH of 3 to 11, oxygen of 0.1 mg / liter or more, and a hydrogen concentration of 0.1 ppm or more. And

本願の請求項３に係る発明は、生理食塩水又は輸液に酸素を１気圧〜１０００気圧で加圧して溶解せしめ、加圧下において、または常圧に戻して得られた生理食塩水又は輸液に水素を１気圧〜１０００気圧で加圧して溶解せしめ、常圧に戻して生理食塩水又は輸液を得る工程を含む生理食塩水又は輸液の製造方法であることを特徴とする。   In the invention according to claim 3 of the present application, oxygen is dissolved in physiological saline or infusion by pressurizing at 1 to 1000 atm, and hydrogen is added to physiological saline or infusion obtained under pressure or by returning to normal pressure. It is characterized by being the manufacturing method of the physiological saline or infusion including the process which pressurizes and melt | dissolves by 1 atmosphere-1000 atmosphere, and returns to a normal pressure and obtaining the physiological saline or infusion.

また、本願の請求項４に係る発明は、生理食塩水又は輸液に水素を１気圧〜１０００気圧で加圧して溶解せしめ、加圧下において、または常圧に戻して得られた生理食塩水及び輸液に酸素を１気圧〜１０００気圧で加圧して溶解せしめ、常圧に戻して生理食塩水又は輸液を得る工程を含む生理食塩水又は輸液の製造方法であることを特徴とする。   In addition, the invention according to claim 4 of the present application is a solution of physiological saline and infusion obtained by pressurizing and dissolving hydrogen in physiological saline or infusion at 1 atm to 1000 atm and returning to normal pressure. It is characterized by being a method for producing a physiological saline or infusion solution, which comprises a step of dissolving oxygen by pressurizing at 1 to 1000 atm, and returning to normal pressure to obtain a physiological saline solution or infusion solution.

また、本願の請求項５に係る発明は、生理食塩水及び輸液に酸素と水素を同時に１気圧〜１０００気圧で加圧して溶解せしめ、常圧に戻して生理食塩水又は輸液を得る工程を含む生理食塩水又は輸液の製造方法であることを特徴とする。   In addition, the invention according to claim 5 of the present application includes the step of simultaneously dissolving oxygen and hydrogen in physiological saline and infusion solution at 1 to 1000 atm, and returning to normal pressure to obtain physiological saline or infusion solution. It is a manufacturing method of physiological saline or infusion.

従来の還元性生理食塩水は酸素の含有量が非常に希薄であり、身体が必要とする酸素量を提供することが不可能であったが、本発明による酸素含有型還元性生理食塩水は身体に必要なる酸素を持ちながら、細胞膜を透過することが可能な水素を多く含有し非常に低い酸化還元力を持つという一見相反する性質を持った生理食塩水又は輸液が提供できるようになる。   Conventional reducing saline has a very low oxygen content and cannot provide the amount of oxygen required by the body, but the oxygen-containing reducing saline according to the present invention is It is possible to provide a physiological saline solution or infusion solution which has a seemingly contradictory property of containing a large amount of hydrogen capable of permeating the cell membrane and having a very low redox power while having oxygen necessary for the body.

以下、本発明の具体例を実施例を用いて詳細に説明する。   Hereinafter, specific examples of the present invention will be described in detail using examples.

本発明は単純に水素を加圧して溶解せしめ、生理食塩水や輸液の酸化還元性を低めるという手法を採用していない。もちろん水素ガスを単純に生理食塩水や輸液の中にバブルしたとき、酸素ガスはほとんど溶存できない。つまり人間に必要な酸素が失われるので、酸素を多く含有しながら水素を多く含有し酸化還元性の低い生理食塩水及び輸液が必要となる。
酸素と水素は常温下では反応しないため、身体の中においては当然反応しない、このことを考慮すると酸素と水素を共に多く含んだ生理食塩水及び輸液を作り出すことが可能となる。 The present invention does not employ a technique of simply pressurizing and dissolving hydrogen to reduce the redox property of physiological saline or infusion. Of course, when hydrogen gas is simply bubbled into physiological saline or infusion, oxygen gas can hardly be dissolved. That is, since oxygen necessary for humans is lost, a physiological saline solution and an infusion solution containing a large amount of hydrogen while containing a large amount of oxygen and low redox properties are required.
Since oxygen and hydrogen do not react at room temperature, they naturally do not react in the body. Taking this into account, it becomes possible to create physiological saline and infusion solutions that contain both oxygen and hydrogen.

本発明の実施例においては、周知の気液接触装置を用い、市販の大塚製薬製造の生理食塩水１リットルに２００ｍリットル／分の割合で８気圧の加圧下で酸素を溶解させ、その後、その酸素含有生理食塩水１リットルに２００ｍリットル／分の割合で８気圧の加圧下で水素を溶解させた。   In an embodiment of the present invention, oxygen is dissolved under a pressure of 8 atm at a rate of 200 ml / min in 1 liter of physiological saline manufactured by Otsuka Pharmaceutical Co., Ltd. Hydrogen was dissolved in 1 liter of oxygen-containing physiological saline at a rate of 200 ml / min under a pressure of 8 atm.

実施例として、３．５６ｍｇ／リットルの酸素含有量を持ちながら、水素濃度が１．３５ｐｐｍであり−６６２ｍｖの酸化還元電位を持つ理想的な還元性生理食塩水ができた。これを表１に示す。なお、酸化還元電位及び酸素量及び水素濃度の測定に関しては、共に東亜ＤＫＫ製ＯＲＰ計測器及び酸素量計測器及び水素濃度測定器を用いた。

Figure 2006273730
As an example, an ideal reducing physiological saline having an oxygen content of 3.56 mg / liter, a hydrogen concentration of 1.35 ppm, and a redox potential of −662 mv was produced. This is shown in Table 1. For the measurement of the oxidation-reduction potential, the oxygen amount, and the hydrogen concentration, an ORP measuring device, an oxygen amount measuring device, and a hydrogen concentration measuring device manufactured by Toa DKK were used.
Figure 2006273730

Claims (5)

酸素を０．１ｍｇ／リットル以上含有し、かつ水素濃度が０．１ｐｐｍ以上の生理食塩水又は輸液。   A physiological saline or infusion solution containing 0.1 mg / liter or more of oxygen and having a hydrogen concentration of 0.1 ppm or more. ｐＨが３〜１１であり、酸素を０．１ｍｇ／リットル以上含有し、かつ水素濃度が０．１ｐｐｍ以上の生理食塩水又は輸液。   A physiological saline or infusion solution having a pH of 3 to 11, oxygen of 0.1 mg / liter or more, and a hydrogen concentration of 0.1 ppm or more. 生理食塩水又は輸液に酸素を１気圧〜１０００気圧で加圧して溶解せしめ、加圧下において、または常圧に戻して得られた生理食塩水又は輸液に水素を１気圧〜１０００気圧で加圧して溶解せしめ、常圧に戻して生理食塩水又は輸液を得る工程を含む生理食塩水又は輸液の製造方法。   Pressurize or dissolve oxygen in physiological saline or infusion solution at 1 to 1000 atmospheres, and pressurize hydrogen in saline or infusion solution obtained under pressure or at normal pressure at 1 to 1000 atmospheres. A method for producing a physiological saline or infusion solution, comprising a step of dissolving and returning to normal pressure to obtain a physiological saline solution or infusion solution. 生理食塩水又は輸液に水素を１気圧〜１０００気圧で加圧して溶解せしめ、加圧下において、または常圧に戻して得られた生理食塩水及び輸液に酸素を１気圧〜１０００気圧で加圧して溶解せしめ、常圧に戻して生理食塩水又は輸液を得る工程を含む生理食塩水又は輸液の製造方法。   Pressurize and dissolve hydrogen in physiological saline or infusion solution at 1 to 1000 atmospheres, and pressurize oxygen or 1 to 1000 atmospheres in physiological saline and infusion solutions obtained under pressure or at normal pressure. A method for producing a physiological saline or infusion solution, comprising a step of dissolving and returning to normal pressure to obtain a physiological saline solution or infusion solution. 生理食塩水及び輸液に酸素と水素を同時に１気圧〜１０００気圧で加圧して溶解せしめ、常圧に戻して生理食塩水又は輸液を得る工程を含む生理食塩水又は輸液の製造方法。   A method for producing a physiological saline or infusion, comprising the steps of simultaneously pressurizing and dissolving oxygen and hydrogen in physiological saline and infusion at 1 to 1000 atm and returning to normal pressure to obtain physiological saline or infusion.
JP2005092553A 2005-03-28 2005-03-28 Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method Pending JP2006273730A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005092553A JP2006273730A (en) 2005-03-28 2005-03-28 Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005092553A JP2006273730A (en) 2005-03-28 2005-03-28 Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method

Publications (1)

Publication Number Publication Date
JP2006273730A true JP2006273730A (en) 2006-10-12

Family

ID=37208823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005092553A Pending JP2006273730A (en) 2005-03-28 2005-03-28 Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method

Country Status (1)

Country Link
JP (1) JP2006273730A (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010508139A (en) * 2006-10-25 2010-03-18 リバルシオ コーポレイション Mixing device and output fluid thereof
US8349191B2 (en) 1997-10-24 2013-01-08 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8591957B2 (en) 2006-10-25 2013-11-26 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
CN103408121A (en) * 2013-07-26 2013-11-27 徐礼鲜 Device for preparing water with dissolved hydrogen and dissolved oxygen through microbubble, replacement, baffle and mixing
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
US8617616B2 (en) 2006-10-25 2013-12-31 Revalesio Corporation Methods of wound care and treatment
JP2014015454A (en) * 2012-06-14 2014-01-30 Takaaki Matsumoto Infusion, infusion production method and infusion apparatus
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US8980325B2 (en) 2008-05-01 2015-03-17 Revalesio Corporation Compositions and methods for treating digestive disorders
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05105625A (en) * 1991-10-15 1993-04-27 Osaka Gas Co Ltd Liquid oxygen carrier
JPH07185554A (en) * 1993-12-28 1995-07-25 Matsuo Seitai Butsuri Kenkyusho:Kk Reducing method of concentration of dissolved oxygen in electrolytically generated water
JPH07185550A (en) * 1993-12-28 1995-07-25 Matsuo Seitai Butsuri Kenkyusho:Kk Electrolytically formed water
JPH0856632A (en) * 1994-08-23 1996-03-05 Kumamoto Pref Gov Reducing hydrogen water for food or the like, its production and producing apparatus
JP2001072595A (en) * 1999-09-07 2001-03-21 Japan Science & Technology Corp Stably storable oxygen transfusion
JP2001137852A (en) * 1999-09-01 2001-05-22 Nippon Torimu:Kk Electrolytic reduction water, cancer suppressing agent and its production method and production device therefor
WO2003002466A1 (en) * 2001-06-29 2003-01-09 Miz Co., Ltd. Method for antioxidation and antioxidative functional water
JP2003019426A (en) * 2001-05-01 2003-01-21 Joho Kagaku Kenkyusho:Kk Method and system for producing gas dissolving liquid medium
JP2003040893A (en) * 2001-07-30 2003-02-13 Japan Science & Technology Corp Porphyrin metal complex and oxygen infusion solution containing the same
WO2004003973A2 (en) * 2002-06-26 2004-01-08 Semequip Inc. Ion implantation device and method
JP2004230370A (en) * 2002-12-05 2004-08-19 Wataru Murota Reduced water and manufacturing method therefor
JP2004329188A (en) * 2003-05-06 2004-11-25 Wataru Murota Reducing tea and method for producing the same
JP2005041848A (en) * 2003-07-25 2005-02-17 Wataru Murota Physiologically active functional water and functional drink
JP2005040765A (en) * 2003-07-25 2005-02-17 Wataru Murota Anti-oxidizing water and anti-oxidizing drink
JP2005053882A (en) * 2003-08-06 2005-03-03 Wataru Murota Reducing physiological salt solution and method for producing the same

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05105625A (en) * 1991-10-15 1993-04-27 Osaka Gas Co Ltd Liquid oxygen carrier
JPH07185554A (en) * 1993-12-28 1995-07-25 Matsuo Seitai Butsuri Kenkyusho:Kk Reducing method of concentration of dissolved oxygen in electrolytically generated water
JPH07185550A (en) * 1993-12-28 1995-07-25 Matsuo Seitai Butsuri Kenkyusho:Kk Electrolytically formed water
JPH0856632A (en) * 1994-08-23 1996-03-05 Kumamoto Pref Gov Reducing hydrogen water for food or the like, its production and producing apparatus
JP2001137852A (en) * 1999-09-01 2001-05-22 Nippon Torimu:Kk Electrolytic reduction water, cancer suppressing agent and its production method and production device therefor
JP2001072595A (en) * 1999-09-07 2001-03-21 Japan Science & Technology Corp Stably storable oxygen transfusion
JP2003019426A (en) * 2001-05-01 2003-01-21 Joho Kagaku Kenkyusho:Kk Method and system for producing gas dissolving liquid medium
WO2003002466A1 (en) * 2001-06-29 2003-01-09 Miz Co., Ltd. Method for antioxidation and antioxidative functional water
JP2003040893A (en) * 2001-07-30 2003-02-13 Japan Science & Technology Corp Porphyrin metal complex and oxygen infusion solution containing the same
WO2004003973A2 (en) * 2002-06-26 2004-01-08 Semequip Inc. Ion implantation device and method
JP2004230370A (en) * 2002-12-05 2004-08-19 Wataru Murota Reduced water and manufacturing method therefor
JP2004329188A (en) * 2003-05-06 2004-11-25 Wataru Murota Reducing tea and method for producing the same
JP2005041848A (en) * 2003-07-25 2005-02-17 Wataru Murota Physiologically active functional water and functional drink
JP2005040765A (en) * 2003-07-25 2005-02-17 Wataru Murota Anti-oxidizing water and anti-oxidizing drink
JP2005053882A (en) * 2003-08-06 2005-03-03 Wataru Murota Reducing physiological salt solution and method for producing the same

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034195B2 (en) 1997-10-24 2015-05-19 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US8349191B2 (en) 1997-10-24 2013-01-08 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US9512398B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US9511333B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US8470893B2 (en) 2006-10-25 2013-06-25 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8591957B2 (en) 2006-10-25 2013-11-26 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8597689B2 (en) 2006-10-25 2013-12-03 Revalesio Corporation Methods of wound care and treatment
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
US8617616B2 (en) 2006-10-25 2013-12-31 Revalesio Corporation Methods of wound care and treatment
US9402803B2 (en) 2006-10-25 2016-08-02 Revalesio Corporation Methods of wound care and treatment
US8449172B2 (en) 2006-10-25 2013-05-28 Revalesio Corporation Mixing device for creating an output mixture by mixing a first material and a second material
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
JP2010508139A (en) * 2006-10-25 2010-03-18 リバルシオ コーポレイション Mixing device and output fluid thereof
US8962700B2 (en) 2006-10-25 2015-02-24 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8410182B2 (en) 2006-10-25 2013-04-02 Revalesio Corporation Mixing device
US9004743B2 (en) 2006-10-25 2015-04-14 Revalesio Corporation Mixing device for creating an output mixture by mixing a first material and a second material
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US8980325B2 (en) 2008-05-01 2015-03-17 Revalesio Corporation Compositions and methods for treating digestive disorders
US9011922B2 (en) 2009-04-27 2015-04-21 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9272000B2 (en) 2009-04-27 2016-03-01 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy
JP2014015454A (en) * 2012-06-14 2014-01-30 Takaaki Matsumoto Infusion, infusion production method and infusion apparatus
CN103408121B (en) * 2013-07-26 2015-07-15 徐礼鲜 Device for preparing water with dissolved hydrogen and dissolved oxygen through microbubble, replacement, baffle and mixing
CN103408121A (en) * 2013-07-26 2013-11-27 徐礼鲜 Device for preparing water with dissolved hydrogen and dissolved oxygen through microbubble, replacement, baffle and mixing

Similar Documents

Publication Publication Date Title
JP2006273730A (en) Oxygen-containing reducing physiological saline or oxygen-containing reducing transfusion and its preparing method
JPWO2006103789A1 (en) Oxygen-containing reducing aqueous beverage and method for producing the same
TWI404547B (en) Water for preparing dialysis solution, dialysis solution formed by the water, manufacture method of the dialysis solution and dialysis apparatus
MX2011009450A (en) Process and apparatus for producing hydrogen-containing biocompatible solution.
Lin et al. The effect of varying water pH on the acidification of expired water in rainbow trout
JP2008036521A (en) Method for activating and stabilizing dissolved hydrogen in water
JP2010527010A5 (en)
JP6183832B2 (en) Oxidative stress-suppressing dialysis agent and preparation method thereof
EP2985028A2 (en) Method for producing hydrogen-containing biological application solution, and exterior body therefor
US20170105832A1 (en) Porous membrane structures and related techniques
CN107715855A (en) A kind of porous carbon materials for being used for organic dyestuff and fluoride wastewater treatment and preparation method thereof
PT1729813E (en) Inclusion complexes containing piroxicam, a cyclodextrin and arginine
JP2006315968A (en) Oxygen-containing reductive collagen and method for producing the same
JP2004329188A (en) Reducing tea and method for producing the same
JP2005053882A (en) Reducing physiological salt solution and method for producing the same
JP2004346053A (en) Reductive skin lotion and method for producing the same
CN105499601B (en) A kind of preparation method of ag nano-cluster
JPWO2006051588A1 (en) Reducing beverage and method for producing the same
SE0400523D0 (en) A medical solution, a method for producing said medical solution and use thereof
JP2004344862A (en) Reducing soft drink and its production method
TW201446640A (en) Capturing and concentration measuring methods of chlorine dioxide gas and chlorine dioxide gas scavenger
JP2010042124A (en) Drug product for dialysis
Morsi et al. Influence of the Fabrication Conditions on the Physical Properties and Water Treatment Efficiency of Cellulose Acetate Porous Membranes
Bae et al. The effect of impulsivity and the ability to recognize facial emotion on the aggressiveness of children with attention-deficit hyperactivity disorder
Durrani Impact of the solvent on stability constant

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071127

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110329

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110404

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111004